Bulk metallic glass nanomoulding for glucose sensors
Bulk metallic glass nanomoulding for glucose sensors
批准号:
10153766
负责人:
THEMIS R KYRIAKIDES
金额:
$41.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2022-05-31
关键词:
AdhesivesAdoptedAlloysArchitectureBiocompatible MaterialsBiologicalBiological AssayBlood GlucoseBlood VesselsCellsCellular AssayChemistryClinicalCollagenCorrosionDiabetes MellitusDiffusionDiseaseEdemaElectrodesEncapsulatedEngineeringEvaluationFibroblastsForeign BodiesForeign-Body Giant CellsGenerationsGeometryGlassGlucoseHealthImplantInfiltrationInflammationInflammatoryInflammatory ResponseInsulinIntercellular FluidLibrariesLongevityMacrophage ActivationMediatingMiniaturizationModificationMonitorMorphologyPatient MonitoringPatientsPatternPlatinumPolymersPorosityPropertyProteinsReactionResistanceSeriesSleepStructureSurfaceSystemTestingTissuesVascularizationZirconiumbasebiomaterial compatibilitycapsulecompliance behaviorcytokinedesigndiabetes managementdiabetic ratexperienceexperimental studyglucose monitorglucose sensorhigh throughput screeningimplantable deviceimprovedimproved functioningin vivolearning materialsmacrophagemetallicitynanopatternnanorodnanoscaleneovascularizationnovelrelease factorresponsescreeningsensortissue injuryvirtual
中文摘要
项目摘要
糖尿病(DM)仍然是一种不治之症,在未来20年内有增加的趋势。
糖尿病的治疗主要是通过胰岛素治疗,这取决于患者监测他们的血液
葡萄糖水平然而,由于缺乏患者依从性,条带传感器不准确,以及无法测试
对于长时间,例如在睡眠期间,患者经历高血糖和低血糖发作。连续
来自留置传感器的葡萄糖监测具有闭环胰岛素输送系统的前景。尽管
传感器设计和整体精度的显著改进,长期成功的障碍
这种传感器的应用仍然存在。其中包括需要小型化,以尽量减少组织损伤
而不会损失灵敏度/准确度、生物污染和异物反应(FBR)。方法以改善
传感器功能包括递送组织改性剂以调节炎症反应。然而,迄今为止,
留置传感器的寿命限于3-14天,
制造业,并产生额外的监管负担。因此,基于生物材料的方法,
调制FBR和改善传感器功能代表了一种有吸引力的解决方案。在本申请中,我们
提出了一种基于块体金属玻璃(BMG)的新型葡萄糖传感器涂层的产生。BMG是
具有无定形原子结构的金属合金,其结合了联合收割机的高耐腐蚀性和聚合物状
加工性能具体而言,我们建议系统地评估铂或锆基BMG
化学性质和几何形状来开发用于留置葡萄糖传感器的生物保护表面。因此,委员会认为,
本申请的具体目的是:1)筛选BMG文库的所需材料性质,
生物学反应; 2)鉴定能够在体内有利地调节的BMG地形特征
响应;和3)整合BMG地形特征,以增强传感器功能。这种生物保护
表面可用于保护几乎任何生物医学植入物免受不良生物反应,
改善植入物的功能和寿命。
英文摘要
Project Summary
Diabetes mellitus (DM) remains an incurable disease that is poised to increase in the next two decades.
Management of DM is mediated primarily by insulin therapy, which depends on patients monitoring their blood
glucose levels. However, due to lack of patient compliance, inaccuracies of strip sensors, and inability to test
for long periods such as during sleep, patients experience hyper- and hypo-glycemic episodes. Continuous
glucose monitoring from indwelling sensors holds the promise of a closed loop insulin delivery system. Despite
significant improvements in sensor design and overall accuracy, obstacles towards the long-term successful
application of such sensors remain. These include the need for miniaturization to minimize tissue injury
without a loss in sensitivity/ accuracy, biofouling, and the foreign body response (FBR). Approaches to improve
sensor function include delivery of tissue modifiers to modulate inflammatory responses. However, to date the
longevity of indwelling sensors is limited to 3-14 days and the inclusion of biologics to sensors complicates
manufacturing and creates additional regulatory burdens. Therefore, a biomaterial-based approach to
modulate the FBR and improve sensor function represents an attractive solution. In this application, we
propose the generation of a novel glucose sensor coating based on bulk metallic glass (BMG). BMGs are
metallic alloys with an amorphous atomic structure that combine high corrosion resistance and polymer-like
processability. Specifically, we propose to systematically evaluate Platinum or Zirconium based BMG
chemistries and geometries to develop a bio-protective surface for an indwelling glucose sensor. Accordingly,
the specific aims of this application are: 1) to screen BMG libraries for desirable material properties and
biological responses; 2) to identify BMG topographical features capable of favorably modulating in vivo
responses; and 3) to integrate BMG topographical features to enhance sensor function. Such bio-protective
surfaces could be used to shield virtually any biomedical implant from adverse biological reactions, thereby
improving implant function and lifespan.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1088/1748-605x/ac5574
发表时间:
2022-03-04
期刊:
Biomedical materials (Bristol, England)
影响因子:
--
作者:
[]
通讯作者:
ECM biomaterials for diabetic foot ulcers
-
批准号:10432878
-
项目类别:
-
资助金额:$45.2万
-
财政年份:2022
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
ECM biomaterials for diabetic foot ulcers
-
批准号:10610940
-
项目类别:
-
资助金额:$48.43万
-
财政年份:2022
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
THE ROLE OF NOVEL AIP1 ISOFORM IN PATHOLOGICAL LYMPHANGIOGENESIS
-
批准号:10218254
-
项目类别:
-
资助金额:$46.58万
-
财政年份:2013
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
THE ROLE OF NOVEL AIP1 ISOFORM IN PATHOLOGICAL LYMPHANGIOGENESIS
-
批准号:10018087
-
项目类别:
-
资助金额:$47.84万
-
财政年份:2013
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
NAVBO's Workshop on Vascular Matrix Biology and Bioengineering
-
批准号:8130114
-
项目类别:
-
资助金额:$2.14万
-
财政年份:2011
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:7027107
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:8258805
-
项目类别:
-
资助金额:$33.59万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:7628682
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:6924404
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:8459007
-
项目类别:
-
资助金额:$32.41万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:7388900
-
项目类别:
-
资助金额:$28.91万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:7354373
-
项目类别:
-
资助金额:$1.47万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:8066395
-
项目类别:
-
资助金额:$33.59万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:7209771
-
项目类别:
-
资助金额:$32.67万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
MCP-1 and attenuation of the foreign body response
-
批准号:7887681
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2005
-
负责人:THEMIS R KYRIAKIDES
-
依托单位:
海外基金